10.1016/j.addr.2007.04.001
10.1016/j.addr.2007.03.011
10.1016/j.addr.2007.03.020
10.1016/j.addr.2007.03.017
10.1016/j.addr.2007.03.019
10.1016/j.addr.2007.03.014
10.1016/j.addr.2007.03.016
10.1016/j.addr.2007.03.018
10.1016/S1369-7021(08)70086-5
10.1016/j.biomaterials.2006.01.039
10.1016/j.actbio.2011.03.027
10.1016/j.biomaterials.2009.10.009
10.1016/S0300-595X(85)80013-X
10.1016/j.matchemphys.2005.06.045
10.1016/S1387-1811(00)00217-1
10.1016/S0142-9612(99)00201-X
10.1016/S0021-9797(03)00083-3
10.1016/j.colsurfa.2006.04.012
10.1016/j.ajic.2004.05.002
10.1016/j.biomaterials.2003.10.078
Dueland R., 1982, Silver antibacterial bone cement, Clin. Orthop. Relat. Res., 169, 264, 10.1097/00003086-198209000-00038
10.1016/S0109-5641(96)80027-3
10.1016/j.biomaterials.2003.08.007
10.1016/j.biomaterials.2011.01.004
10.1007/s10856-009-3941-8
Davis R. R., 2010, Titanate particles as agents to deliver gold compounds to fibroblasts and monocytes, J. Biomed. Mater. Res. A, 93, 864, 10.1002/jbm.a.32407
10.1016/S0889-857X(05)70111-3
10.1080/07315724.1993.10718327
10.1016/j.actbio.2008.07.032
Guindy J. S., 2004, Corrosion at the marginal gap of implant-supported suprastructures and implant failure, Int. J. Oral Maxillofac. Implants, 19, 826
10.1089/ten.tea.2007.0370
Di Nunzio S.& Verné E.. 2005 Process for the production of silver-containing prosthetic devices . PCT/EP2005/056391.
10.1089/107632702753503045
10.1016/j.ejps.2009.02.011
10.1016/0142-9612(96)87284-X
10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
10.1016/j.cej.2007.07.083
10.1016/j.biomaterials.2006.07.003
10.1007/s10856-006-0434-x
10.1016/S0142-9612(03)00524-6
10.1002/(SICI)1097-4636(199910)47:1<18::AID-JBM3>3.0.CO;2-T
10.1016/j.biomaterials.2007.09.040
Castro C., 2005, Two-month ciprofloxacin implants for multibacterial bone infections, Eur. J. Pharm. Sci., 60, 401
10.1023/B:JMSM.0000046393.81449.a5
10.1023/B:JMSM.0000021092.03087.d4
10.1097/00002480-200201000-00004
10.1016/j.polymer.2005.05.068
10.1016/S0142-9612(02)00139-4
10.1016/j.biomaterials.2004.01.063
Tan K. H., 2005, Selective laser sintering of biocompatible polymers for applications in tissue engineering, Biomed. Mater. Eng., 15, 113
10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.0.CO;2-7
10.1108/13552540510573347
10.1016/S0142-9612(00)00121-6
10.1016/j.tibtech.2004.05.005
10.1016/S0142-9612(03)00030-9
10.1163/156856208784089571
10.1016/j.addr.2004.05.001
10.1016/j.tibtech.2004.10.004
10.1208/s12249-009-9308-0
10.1111/j.1151-2916.1998.tb02540.x
10.1098/rsif.2010.0151.focus
10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D
10.1016/j.biomaterials.2003.07.001
10.1016/j.biomaterials.2004.01.043
10.1089/ten.teb.2009.0416
10.1016/S1369-7021(09)70273-1
10.1016/j.biomaterials.2006.12.027
10.1016/S1748-0132(07)70171-8
Shanov V. et al. 2008 UC 108-091 invention disclosure composition and method for producing magnesium based biodegradable composite implants . Chichester UK: John Wiley & Sons Ltd.
Mast D. Shanov V. Jayasinghe C.& Schulz M.. 2008 UC 109-035 invention disclosure ‘use of carbon nanotube thread ribbon and arrays for the transmission and reception of electromagnetic signals and radiation’ . Chichester UK: John Wiley & Sons Ltd.
Schulz M. J et al. 2009 UC 109-085 invention disclosure corrosion measurement for biodegradable metal implants . Chichester UK: John Wiley & Sons Ltd.
Schulz M. J. Shanov V. N. Sankar J. Witte F. Wagner W. Borovetz H. Kumta P.& Sfeir C.. 2009 UC 109-111 invention disclosure permanent and biodegradable responsive implants that expand and adapt to the human body . Chichester UK: John Wiley & Sons Ltd.
Shanov V. et al. 2009 UC 109-089 invention disclosure composition and method for magnesium biodegradable material for medical implant applications . Chichester UK: John Wiley & Sons Ltd.
10.1016/j.cirp.2007.05.029
10.1088/0957-4484/18/46/465505
10.1088/1748-6041/4/2/025008
10.1016/j.biomaterials.2009.08.007
10.1016/j.ceca.2005.01.007
10.1016/j.neuron.2005.04.022
10.1016/j.jhsb.2004.11.003
10.1007/s10856-010-4083-8
10.1016/j.biomaterials.2005.01.006
10.1016/j.bone.2009.07.082
10.1088/1748-6041/4/4/045011
10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
10.1016/j.biomaterials.2010.01.083
10.1016/j.biomaterials.2005.01.043
10.1016/j.abb.2003.09.013
10.1634/stemcells.2006-0347
Loboda A., 2005, Heme oxygenase-1-dependent and -independent regulation of angiogenic genes expression: effect of cobalt protoporphyrin and cobalt chloride on VEGF and IL-8 synthesis in human microvascular endothelial cells, Cell Mol. Biol., 51, 347
10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A
10.1111/j.1600-0773.1986.tb02781.x
10.1016/j.mam.2005.07.010
Linder M. C., 1996, Copper biochemistry and molecular biology, Am. J. Clin. Nutr., 63, 797S
10.1016/S1040-8428(01)00225-6
10.1097/01.shk.0000068318.49350.3a
10.1016/j.biomaterials.2004.07.024
10.1016/j.biomaterials.2004.08.027
10.1016/j.biomaterials.2009.10.009
10.1016/j.mehy.2007.06.006
10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A
10.1152/ajpheart.01015.2001
Parke A., 1998, Characterization and quantification of copper sulphate induced vascularization of the rabbit cornea, Am. J. Pathol., 130, 173
10.7326/0003-4819-113-11-847
Warrell R. P., 1985, Metabolic effects of gallium nitrate administered by prolonged infusion, Cancer Treat. Rep., 69, 653
Bernstein L. R., 1998, Mechanisms of therapeutic activity for gallium, Pharmacol. Rev., 50, 665
10.1111/j.1476-5381.2010.00665.x
10.1016/j.actbio.2008.09.019
10.1161/01.ATV.0000190610.63878.20
10.1371/journal.pbio.0000079
10.1016/j.biomaterials.2003.10.013
10.1007/s00223-001-1091-1
10.1016/S0027-5107(01)00074-4
10.1016/S0142-9612(03)00414-9
10.1016/S0898-8838(08)60152-X
10.1016/S0165-0173(02)00234-5
Westenberg D., 2000, Proc. 100th General Meeting of the American Society for Microbiology
10.1002/(SICI)1097-4636(19970905)36:3<325::AID-JBM7>3.0.CO;2-G
10.1002/(SICI)1097-4636(19991215)47:4<516::AID-JBM7>3.0.CO;2-E
10.1002/(SICI)1097-4636(1999)48:3<277::AID-JBM11>3.0.CO;2-T
10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D
10.1016/S0924-8579(00)00360-5
10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
10.1016/S8756-3282(01)00419-7
10.1016/8756-3282(95)00484-X
10.1016/j.bbrc.2007.01.120
Posner B. I., 1994, Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics, J. Biol. Chem., 269, 4596, 10.1016/S0021-9258(17)41818-7
Crans D. C., 1998, Vanadium compounds: chemistry, biochemistry, and therapeutic applications,, 82, 10.1021/bk-1998-0711.ch006
10.1016/S0162-0134(00)00033-7
10.1016/S0162-0134(00)00035-0
Scior T., 2010, Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B, Drug Des. Dev. Ther., 4, 231
10.1016/j.cclet.2008.07.002
10.1016/j.jinorgbio.2008.06.007
10.1007/s10529-004-7855-8
10.1007/s10534-007-9109-4
10.1016/j.biocel.2005.12.007
10.1016/S0946-672X(97)80035-1
Barrio D. A., 2003, Synthesis of a new vanadyl(IV) complex with trehalose (TreVO): insulin-mimetic activities in osteoblast-like cells in culture, J. Biol. Metallic Chem., 8, 459
Etcheverry S. B., 2002, Three new vanadyl(IV) complexes with non-steroidal anti-inflammatory drugs (Ibuprofen, Naproxen and Tolmetin). Bioactivity on osteoblast-like cells in culture, J. Metallic Biochem., 88, 94
10.1016/0006-2952(88)90098-6
10.1016/S8756-3282(01)00616-0
10.1016/j.actbio.2009.04.006
10.1523/JNEUROSCI.23-06-02284.2003
10.1016/0006-2952(87)90471-0
10.1016/j.bone.2009.11.003
10.1016/j.neuint.2006.12.001
10.1152/ajplung.00280.2006
10.1016/S0924-8579(02)00115-2
10.1111/j.1524-475X.2006.00179.x
10.1016/j.actbio.2008.09.004
Chen X., 2010, Synthesis and characterization of novel multiphase bioactive glass–ceramics in the CaO–MgO–SiO2 system, J. Biomed. Mater. Res. B, 93, 194, 10.1002/jbm.b.31574
10.1016/j.msec.2008.07.004
10.1088/1742-6596/187/1/012024
10.1002/1097-4636(20000905)51:3<484::AID-JBM24>3.0.CO;2-4
10.1128/AAC.46.6.1940-1945.2002
10.1007/s10856-011-4240-8
10.1016/j.actbio.2007.05.006
10.1007/s10856-009-3920-0
10.1016/j.biomaterials.2010.01.121
Zhang M. L., 2010, Synthesis, in vitro hydroxyapatite forming ability, and cytocompatibility of strontium silicate powders, J. Biomed. Mater. Res. B Appl. Biomater., 93, 252, 10.1002/jbm.b.31582
10.1016/j.actbio.2010.12.018
10.1016/j.actbio.2006.09.005
10.1088/1748-6041/2/1/003
10.1007/s10856-006-8930-6
10.1016/j.actbio.2008.10.020
10.1007/s10856-009-3789-y
10.1016/j.biomaterials.2010.01.024
10.1016/j.actbio.2009.04.010
10.1007/s10856-008-3569-0
10.1016/j.arth.2004.09.010
